ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹466 Cr | ₹757 Cr | ₹67 Cr | ₹33 Cr | ₹23 Cr |
What is the latest Total Non-Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹757 Cr |
| Mar2023 | ₹67 Cr |
| Mar2022 | ₹33 Cr |
| Mar2021 | ₹23 Cr |
How is Total Non-Current Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹466 Cr | -38.43 | |
| Mar2024 | ₹757 Cr | 1,023.14 | |
| Mar2023 | ₹67 Cr | 106.11 | |
| Mar2022 | ₹33 Cr | 42.87 | |
| Mar2021 | ₹23 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹12,800.1 Cr | 5.1% | 13.6% | -1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | 5.1% |
13.6% |
-1.6% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses